Jazz Venture Partners
VC Fund
San Francisco, United States
Jazz Venture Partners is a VC fund in San Francisco focused on Health Care and Artificial Intelligence. JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impactingthe human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment.The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.
- Total investments:
- 96
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $19M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Jazz Venture Partners invests in
Stages Jazz Venture Partners invests in
Countries Jazz Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.5M–$12M
- Series A
- $5M–$45M
- Series B
- $13M–$90M
Investment Focus
Industry
- Health Care 20 (21%)
- Artificial Intelligence 17 (18%)
- Software 16 (17%)
- Biotechnology 11 (11%)
- Medical 10 (10%)
Stage
- Series A 32 (33%)
- Series B 22 (23%)
- Seed 12 (13%)
- Series C 5 (5%)
- Funding Round 3 (3%)
Country
- United States 52 (54%)
- Canada 1 (1%)
- Israel 1 (1%)
- Finland 1 (1%)
- Germany 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
John F. Harris
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 0 | Find email | |
John F. Harris
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 5 | Find email | |
John Spinale
Co-Founder, Managing Partner
|
Co-Founder, Managing Partner | Total investments: 12 | Find email | |
Zack Lynch
Co-founder, General Partner
|
Co-founder, General Partner | Total investments: 6 | Find email | |
Adam Gazzaley
Co-Founder & Chief Scientist
|
Co-Founder & Chief Scientist | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Transcripta Bio
|
Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance. | $24M / Series A / Jul 22, 2026 | |
Justpoint
|
Justpoint is the artificial intelligence-powered platform connecting people with the right litigation attorney and tools. Using predictive analytics rather than billboards, Justpoint brings transparency, simplicity, and credibility to the process of finding litigators in the personal injury space. For attorneys, Justpoint takes on back-office taskswhile creating efficiencies in the discovery process so they can quickly understand a claim's merit and obtain the best results. With over 1000 law firms, more than 300,000 historical claims, and operations in 33 states, Justpoint’s team of attorneys, engineers, and doctors are dedicated to increasing access to justice. For more information visit https://justpoint.com. | $45M / Series A / Feb 12, 2025 | |
KLOWEN Braces
|
KLOWEN Braces offers braces system that uses prefabricated, modular brackets to straighten teeth, faster, better, and more comfortable than conventional braces. It was established in 2019 and is based in Fort Collins, Colorado, United States. | $25.5M / Series B / Oct 11, 2024 | |
Pinpoint Predictive
|
Pinpoint Predictive offers property and casualty insurers loss predictions and risk scores with only a name and address. Their platform allows insurers to leverage unmatched risk selection at the beginning of the customer journey. | $23M / Series A / Oct 08, 2024 | |
Enveda Biosciences
|
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California. | $55M / Series B / Jun 14, 2024 | |
Bonito Biosciences
|
Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules. | $9M / Seed / May 31, 2024 | |
|
Transcripta Bio
|
Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance. | $10M / Venture - Series Unknown / Apr 29, 2024 | |
Reken
|
Reken is an AI & cybersecurity firm building a new type of AI platform and products to protect against generative AI-enabled threats, including deepfake social engineering and automated fraud. The company was founded in 2024 and is based in San Francisco, California. | $10M / Seed / Jan 31, 2024 | |
|
Reken
|
Reken is an AI & cybersecurity firm building a new type of AI platform and products to protect against generative AI-enabled threats, including deepfake social engineering and automated fraud. The company was founded in 2024 and is based in San Francisco, California. | $10M / Seed / Jan 31, 2024 | |
Evolv
|
Evolv is in healthcare, offering weight loss supplements and healthcare solutions. | $5.8M / Pre-Seed / Jan 31, 2024 | |
| See all 96 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Jazz Venture Partners invest in?
Jazz Venture Partners invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Series A and Series B stage. Most of the 96 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jazz Venture Partners's check size?
Jazz Venture Partners typically joins rounds of $2.5M–$12M at Seed, $5M–$45M at Series A and $13M–$90M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jazz Venture Partners participates in.
How do I contact Jazz Venture Partners?
Public channels for Jazz Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Jazz Venture Partners?
The team at Jazz Venture Partners includes John F. Harris (Co-Founder and Managing Partner), John F. Harris (Co-Founder and Managing Partner) and John Spinale (Co-Founder, Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
